Featured Research

from universities, journals, and other organizations

Novel stroke treatment passes safety stage of clinical trial

Date:
March 11, 2010
Source:
University of California - Irvine
Summary:
A clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage, according to the neurologist who led the effort.

A clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage, according to the UC Irvine neurologist who led the effort.

Dr. Steven C. Cramer said patients showed no ill effects after the sequential administration of growth factors encouraging the creation of neurons in stroke-damaged areas of the brain. All new drug treatments must pass this safety stage before doctors can study their effectiveness in subsequent studies.

Results of the phase IIa trial appear on the Web site of Stroke, a journal of the American Heart Association.

Within two days of suffering ischemic stroke, patients were put on a nine-day treatment course, starting with three once-daily injections of beta-hCG, a hormone that triggers the growth of neural stem cells. They then received three once-daily injections of erythropoietin, a hormone that directs these neural stem cells to become neurons.

Cramer, associate professor of neurology at UCI, said this combination of growth factors had been shown in animal studies to engender neuron creation leading to the recovery of a range of movement.

In the human safety study, he teamed with physicians from UC Irvine Medical Center; Hoag Memorial Hospital Presbyterian in Newport Beach, Calif.; and the University of Calgary in Canada. They administered the treatment to 15 patients. No safety concerns were noted, and a majority of treated patients had minimal or no disability after three months.

A phase IIb clinical trial is now under way to compare the stroke therapy with placebo.

The study is supported by Stem Cell Therapeutics -- a Canadian biotechnology company that conceived of an approach using this specific sequence of growth factors -- and the National Center for Research Resources.


Story Source:

The above story is based on materials provided by University of California - Irvine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Steven C. Cramer, Camille Fitzpatrick, Michael Warren, Michael D. Hill, David Brown, Laura Whitaker, Karla J. Ryckborst, and Lawrence Plon. The Beta-hCG Erythropoietin in Acute Stroke (BETAS) Study. A 3-Center, Single-Dose, Open-Label, Noncontrolled, Phase IIa Safety Trial Stroke. Stroke, March 2010 DOI: 10.1161/STROKEAHA.109.574343

Cite This Page:

University of California - Irvine. "Novel stroke treatment passes safety stage of clinical trial." ScienceDaily. ScienceDaily, 11 March 2010. <www.sciencedaily.com/releases/2010/03/100310134200.htm>.
University of California - Irvine. (2010, March 11). Novel stroke treatment passes safety stage of clinical trial. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2010/03/100310134200.htm
University of California - Irvine. "Novel stroke treatment passes safety stage of clinical trial." ScienceDaily. www.sciencedaily.com/releases/2010/03/100310134200.htm (accessed August 1, 2014).

Share This




More Mind & Brain News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Google (Kind Of) Complies With 'Right To Be Forgotten Law'

Google (Kind Of) Complies With 'Right To Be Forgotten Law'

Newsy (July 31, 2014) Google says it is following Europe's new "Right To Be Forgotten Law," which eliminates user information upon request, but only to a certain degree. Video provided by Newsy
Powered by NewsLook.com
Stroke Signs: Three Hour Deadline

Stroke Signs: Three Hour Deadline

Ivanhoe (July 31, 2014) Sometimes the signs of a stroke are far from easy to recognize. Learn from one young father’s story on the signs of a stroke. Video provided by Ivanhoe
Powered by NewsLook.com
Grain Brain May Be Harming Us

Grain Brain May Be Harming Us

Ivanhoe (July 31, 2014) Could eating carbohydrates be harmful to our brain health? Find out what one neurologist says about changing our diets. Video provided by Ivanhoe
Powered by NewsLook.com
Playground Tales: Learning to Socialize With Autism

Playground Tales: Learning to Socialize With Autism

Ivanhoe (July 31, 2014) Playgrounds are typically great places where kids can have fun while learning how to interact with other kids, but for some kids with autism, they can have the reverse effect. Hear how researchers are trying to change that. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins